Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

<jats:title>Abstract</jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>We investigate the joint observation between type 2 diabetes and headache using a case-control study of a US ambulatory dataset.</jats:p></jats:sec><jats:sec><jats:title>Background</jats:title><jats:p>Recent whole-population cohort studies propose that type 2 diabetes may have a protective effect against headache prevalence. With headaches ranked as a leading cause of disability, headache-associated comorbidities could help identify shared molecular mechanisms.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We performed a case-control study using the US National Ambulatory Medical Care Survey, 2009, on the joint observation between headache and specific comorbidities, namely type 2 diabetes, hypertension and anxiety, for all patients between 18 and 65 years of age. The odds ratio of having a headache and a comorbidity were calculated using conditional logistic regression, controlling for gender and age over a study population of 3,327,947 electronic health records in the absence of prescription medication data.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>We observed estimated odds ratio of 0.89 (95% CI: 0.83-0.95) of having a headache and a record of type 2 diabetes over the population, and 0.83 (95% CI: 2.02-2.57) and 0.89 (95% CI: 3.00-3.49) for male and female, respectively.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>We find that patients with type 2 diabetes are less likely to present a recorded headache indication. Patients with hypertension are almost twice as likely of having a headache indication and patients with an anxiety disorder are almost three times as likely. Given the possibility of confounding indications and prescribed medications, additional studies are recommended.</jats:p></jats:sec>

Original publication

DOI

10.1101/336586

Type

Journal article

Publisher

Cold Spring Harbor Laboratory

Publication Date

04/06/2018